Literature DB >> 12022494

Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type.

K S Soppimath1, T M Aminabhavi.   

Abstract

This study deals with the production of poly(DL-lactide-co-glycolide) (PLGA) microspheres using ethyl acetate as a dispersing solvent, a partially water soluble and less toxic solvent, by using emulsification and solvent diffusion/ evaporation techniques. PLGA 50 : 50 was used, having molecular weights, 12000 and 34000 with the end group capped (RG502, 503) and uncapped (RG502H, 503H) biodegradable polymers. The microspheres were loaded with nifedipine (NFD) as a model drug. Solvent removal from the embryonic microspheres was manipulated by adopting different techniques. These methods have shown a significant effect on the physicochemical and release characteristics of the microspheres. Rapid removal of the solvent resulted in microspheres with a loose matrix and large size. Use of higher molecular weight polymers increased the size of the microspheres as well as delayed release of the drug. The uncapped polymer has given a higher rate of diffusion when compared to the capped polymers. Thermal analyses showed a uniform molecular distribution of the drug in the polymer matrix. The mechanism of drug release from the PLGA microspheres followed the Fickian diffusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022494     DOI: 10.1080/02652040110105319

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  8 in total

1.  Solvent exchange method: a novel microencapsulation technique using dual microdispensers.

Authors:  Yoon Yeo; Alvin U Chen; Osman A Basaran; Kinam Park
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Improved enzyme activity and stability in polymer microspheres by encapsulation of protein nanospheres.

Authors:  Brenda L Montalvo-Ortiz; Brian Sosa; Kai Griebenow
Journal:  AAPS PharmSciTech       Date:  2012-04-27       Impact factor: 3.246

3.  Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement.

Authors:  Ingrid J Castellanos; Kai Griebenow
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 4.  Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles.

Authors:  Kinam Park; Andrew Otte; Farrokh Sharifi; John Garner; Sarah Skidmore; Haesun Park; Young Kuk Jhon; Bin Qin; Yan Wang
Journal:  J Control Release       Date:  2020-10-24       Impact factor: 11.467

5.  Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process.

Authors:  Hyunjin Shim; Hongkee Sah
Journal:  Pharmaceutics       Date:  2020-05-06       Impact factor: 6.321

6.  Prevention of lens epithelial cell growth in vitro using mibefradil-containing PLGA micro particles.

Authors:  Arne Weidmann; Sabine Kwittner; Ria Beck; Joachim Teller; Ludwig Jonas; J Barbara Nebe
Journal:  Open Ophthalmol J       Date:  2008-06-12

Review 7.  Interfacial tension effects on the properties of PLGA microparticles.

Authors:  Andrew Otte; Farrokh Sharifi; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2020-08-23       Impact factor: 5.999

8.  Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles.

Authors:  Sheikh Tasnim Jahan; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2015-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.